Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
HYPERION THERAPEUTICS INC (HPTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2016 SC 13G/A Consonance Capital Management LP reports a 12% stake in Hyperion Therapeutics, Inc.
05/15/2015 SC 13D/A SOFINNOVA VENTURE PARTNERS VII L P reports a 0% stake in Hyperion Therapeutics, Inc.
05/11/2015 SC 13D/A New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Hyperion Therapeutics, Inc.
05/07/2015 8-K Form 8-K - Current report
05/07/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/07/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/06/2015 10-Q Quarterly Report for the period ended March 31, 2015
04/30/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/30/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/29/2015 10-K/A Annual Report for the period ended December 31, 2014 [amend]
04/27/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/23/2015 SC 13D GAMCO INVESTORS, INC. ET AL reports a 2.9% stake in Hyperion Therapeutics, Inc.
04/22/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/21/2015 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/14/2015 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/10/2015 SC 13G/A FMR LLC reports a 9.6% stake in HYPERION THERAPEUTICS INC
04/09/2015 8-K Results of Operations and Financial Condition
04/09/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
04/09/2015 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
04/09/2015 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Horizon Pharma, Inc., Ghrian Acquisition Inc. and Hyperion Therapeutics, Inc"
04/09/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
04/09/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
04/07/2015 SC 13D/A New Enterprise Associates 12, Limited Partnership reports a 11.5% stake in Hyperion Therapeutics, Inc.
04/03/2015 SC 13D/A SOFINNOVA VENTURE PARTNERS VII L P reports a 9.5% stake in Hyperion Therapeutics, Inc.
03/31/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
03/30/2015 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/30/2015 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Horizon Pharma Inc., Ghrian Acquisition Inc. and Hyperion Therapeutics, Inc",
"Form of Tender and Support Agreement, by and among Horizon Pharma, Inc., Ghrian Aquistion Inc. and each of the Principal Stockholders",
"Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per share or $1.1 Billion in Cash"
03/30/2015 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
03/12/2015 SC 13D/A BAY CITY CAPITAL LLC reports a 7.5% stake in Hyperion Therapeutics, Inc.
03/10/2015 SC 13D/A Panorama Capital, L.P. reports a 4.8% stake in * Hyperion Therapeutics, Inc.
03/04/2015 10-K Annual Report for the period ended December 31, 2014
02/26/2015 8-K Quarterly results
02/17/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Hyperion Therapeutics Enters Into Completion of Phase III Clinical Trial, Option and Mutual Release Agreement with Clal Biotechnology Industries and Yeda Research and Development Company"
02/17/2015 SC 13G Consonance Capital Management LP reports a 6% stake in Hyperion Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy